Patent · US Active

Antibodies against human CSF-1R and uses thereof

US9879085B2 · kind B2 · utility

12Cited by

32References

20Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Nikolaos Dimoudis · Wielenbach, DE
Georg Fertig · Penzberg, DE
Alexander Fidler · Penzberg, DE
Klaus Kaluza · Bad Heilbrunn, DE
Marlene Thomas · Penzberg, DE
Carola Ries · Penzberg, DE
Stefan Seeber · Penzberg, DE
Martin Lanzendoerfer · Tutzing, DE

Key dates

Filing date	Apr 17, 2017
Grant date	Jan 30, 2018
Priority date	—
Expiry date	Apr 17, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.